ISARIC
  • Home
  • About us
    • Membership
    • Joining
    • Fellowships
    • People
    • News
    • Events
  • Capacity
    • Clinical Research During Outbreaks (CREDO)
    • ISARIC Regional Hubs
    • Career Development Fellowship Scheme
  • Research
    • Partner Analyses
    • Monkeypox
    • COVID-19
    • Bubonic plague
    • Lassa fever resources
    • Severe Acute Hepatitis
    • Ebola
  • Document Library
Select Page

Time to reconsider the role of ribavirin in Lassa fever

by Liliana Resende | Jul 8, 2021 | News

Ribavirin is the only available Lassa fever–specific treatment and has been used routinely for over 25 years. However, Ribavirin is not licensed for Lassa fever, its mechanism of action is unclear, it’s expensive and hard to source, and it has well-known...





© ISARIC 2020 | Privacy Policy | Accessibility | Website Terms of Use | Contact Us | Site by Herd

Cookies Policy

Our Website uses cookies to improve your experience. Please visit our Cookies page for more information about cookies and how we use them.

Close